There are studies in which EVs are used for early tumor detection; for example, an increasing number of cell surface proteoglycans glypican-1, (Melo et al., 2015), and KRAS mutations can be used as adjuncts for early detection of pancreatic cancers (Melo et al., 2015). This evidence concerns the gene KRAS and familial pancreatic carcinoma.